Aug 2026· International Journal of Advanced Research in Science, Communication and Technology· 0 citations
TL;DR
By comparing genomic and multi-omics strategies, this survey highlights ongoing hurdles related to privacy, bias, interpretability, and scalability.
Abstract
artificial intelligence (AI) is transforming the way we stumble on ailments early, but relying on a single form of facts—which includes genomics on my own—offers most effective a restrained picture of the whole organic complexity. Multi-omics integration—alongside aspect genomics, transcriptomics, proteomics, metabolomics, microbiome information, and scientific signs and symptoms and signs and symptoms—offers a more whole view of illness improvement. modern-day-day research show that graph neural networks (GNNs), federated getting to know (FL), and explainable AI (XAI) outperform genomic-most effective models through identifying novel biomarkers and enhancing diagnostic accuracy. Examples embody Tab net fusion for Alzheimer’s, multimodal deep reading for rheumatoid arthritis, and semi-supervised analyzing for hepatocellular carcinoma. By comparing genomic and multi-omics strategies, this survey highlights ongoing hurdles related to privacy, bias, interpretability, and scalability. destiny tips which consist of transformer-based fusion and basis fashions promise equitable, transparent, and clinically relevant AI-driven multi-omics structures for precision medicine.
This review aims to summarize the current status of the artificial intelligence (AI)-based multi-omics diagnostic workflows employed in three disease paradigms: infectious, neurodegenerative, and metabolic diseases, and critically evaluate their translational potential from the discovery of biomarkers to digital twin h...
Emmanuel Nkansah, M. Oladosu, M. Abah et al.· International Journal of Pre...· 0 citations
Precision phenomics is introduced as a unifying framework that links molecular, spatial, functional, and clinical characteristics of tumors to support personalized cancer management and has the potential to transform lung cancer research and improve patient outcomes.
Recent developments in AI-driven multi-omics approaches for the discovery of BC biomarkers are summarized and future perspectives on the integration of AI and multi-omics to revolutionize precision clinical medicine and improve clinical outcomes in BC theranostics are outlined.
V. Kumari, Harshita Tiwari, Swati Singh et al.· Medicinal research reviews (...· 2 citations
How artificial intelligence (AI)-powered multi-omics data integration can be a catalyst in discovering drug targets, identifying biomarkers, and stratifying patients for AD is discussed.
T. Periyasamy, Nishu Sekar, Hariprasath Lakshmanan· Journal of Alzheimer's Disea...· 0 citations
This review synthesizes key developments in ML for oncology, covering foundational algorithms alongside emerging approaches, and describes future directions, including federated learning, graph neural networks, longitudinal modeling, and integration of real-world and wearable data to support precision oncology.
Kanishk Yadav, Taneesha Gupta· Journal of the Egyptian Nati...· 0 citations
An AI-based multi-omics integration therefore provides a promising strategy to capture the complex regulatory networks linking tumor metabolism, genetic alterations, and therapeutic response.
Anjali Ashok Thumbarambil, Senthil Madasamy· Current Pharmacogenomics and...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.